Beloqui A - Search Results

1

Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.

Beloqui A, Solinís MÁ, des Rieux A, Préat V, Rodríguez-Gascón A. Beloqui A, et al. Int J Pharm. 2014 Jul 1;468(1-2):105-11. doi: 10.1016/j.ijpharm.2014.04.027. Epub 2014 Apr 16. Int J Pharm. 2014. PMID: 24746410

2

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. Beloqui A, et al. J Control Release. 2013 Mar 10;166(2):115-23. doi: 10.1016/j.jconrel.2012.12.021. Epub 2012 Dec 22. J Control Release. 2013. PMID: 23266764

3

Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.

Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez-Gascón A. Beloqui A, et al. Eur J Pharm Biopharm. 2013 Jun;84(2):309-14. doi: 10.1016/j.ejpb.2013.01.029. Epub 2013 Feb 24. Eur J Pharm Biopharm. 2013. PMID: 23461861

4

Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.

Beloqui A, Solinís MÁ, Delgado A, Evora C, Isla A, Rodríguez-Gascón A. Beloqui A, et al. J Microencapsul. 2014;31(1):1-8. doi: 10.3109/02652048.2013.788090. Epub 2013 Apr 30. J Microencapsul. 2014. PMID: 23631381

5

Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.

Beloqui A, Coco R, Alhouayek M, Solinís MÁ, Rodríguez-Gascón A, Muccioli GG, Préat V. Beloqui A, et al. Int J Pharm. 2013 Oct 1;454(2):775-83. doi: 10.1016/j.ijpharm.2013.05.017. Epub 2013 May 18. Int J Pharm. 2013. PMID: 23694806

6

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.

Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Préat V. Beloqui A, et al. Int J Pharm. 2014 Oct 1;473(1-2):203-12. doi: 10.1016/j.ijpharm.2014.07.009. Epub 2014 Jul 8. Int J Pharm. 2014. PMID: 25014369

7

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Beloqui A, et al. Nanomedicine. 2016 Jan;12(1):143-61. doi: 10.1016/j.nano.2015.09.004. Epub 2015 Sep 26. Nanomedicine. 2016. PMID: 26410277 Review.

8

Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles.

Bouttefeux O, Beloqui A, Preat V. Bouttefeux O, et al. Among authors: beloqui a. Curr Pharm Des. 2016;22(9):1161-76. doi: 10.2174/1381612822666151216150238. Curr Pharm Des. 2016. PMID: 26675223 Review.

9

Nanoparticle transport across in vitro olfactory cell monolayers.

Gartziandia O, Egusquiaguirre SP, Bianco J, Pedraz JL, Igartua M, Hernandez RM, Préat V, Beloqui A. Gartziandia O, et al. Among authors: beloqui a. Int J Pharm. 2016 Feb 29;499(1-2):81-89. doi: 10.1016/j.ijpharm.2015.12.046. Epub 2015 Dec 22. Int J Pharm. 2016. PMID: 26721725

10

Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.

Guada M, Beloqui A, Kumar MN, Préat V, Dios-Viéitez Mdel C, Blanco-Prieto MJ. Guada M, et al. Among authors: beloqui a. J Control Release. 2016 Mar 10;225:269-82. doi: 10.1016/j.jconrel.2016.01.056. Epub 2016 Jan 30. J Control Release. 2016. PMID: 26829101 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters